查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1802977

全球经皮烟碱酰胺市场：2032 年预测 - 按产品形式、分销管道、应用和地区分析

Transdermal Niacinamide Market Forecasts to 2032 - Global Analysis By Product Form, Distribution Channel, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球经皮烟碱酰胺市场预计在 2025 年达到 7,087 万美元，到 2032 年达到 1.1306 亿美元，预测期内复合年增长率为 6.9%。

经皮烟碱酰胺是一种皮肤科和医学美容解决方案，可透过贴片、凝胶和乳霜等先进剂型将维生素B3直接输送至皮肤。这种方法可以解决痤疮、色素沉淀和发炎等特定问题，同时提高生物利用度并绕过口服代谢。人们对非侵入性治疗的日益偏好、循证皮肤护肤以及个性化皮肤病学的广泛趋势推动了其应用，使其成为医学美容和皮肤病学实践中一个充满希望的领域。

根据Springer的《药物输送与转化研究》（2024），烟碱酰胺因其美肤、抗衰老和保护皮肤屏障的特性，广泛应用于局部製剂。非处方产品中的烟碱酰胺浓度高达20%，其功效与其在NAD+/NADH代谢中的作用有关。

皮肤病增多

随着皮肤病患病率的上升，消费者寻求有效治疗色素沉淀、痤疮和异位性皮肤炎等疾病，这也推动了经皮烟碱酰胺剂型的进一步普及。人们日益认识到烟碱酰胺的皮肤病益处，例如改善皮肤屏障功能和增强保湿效果，这进一步增强了治疗和化妆品领域的需求。此外，全球老龄化人口的不断增长也推动了人们对皮肤病问题的日益关注。此外，近期护肤品输送系统的创新使得烟碱酰胺能够更有效地整合，从而积极促进市场稳定扩张。

先进的经经皮给药系统高成本

微针贴片、奈米颗粒载体和封装技术等先进给药机制的高成本正在阻碍药物的成长。虽然这些创新提高了生物有效性，但也显着提高了产品开发和消费者价格，限制了其大规模应用。此外，在高度监管的市场中，製造商面临着不断上升的研发和合规成本，进一步限制了其可负担性。此外，在新兴经济体中，这些药物通常难以与传统的口服和外用製剂相比保持成本竞争力。这种价格敏感性可能会限制药物的使用，并延缓更广泛的市场渗透。

开发新型交付机制

新型递送机制的开发正在整合奈米技术、微针和水凝胶系统，以提升皮肤渗透性。先进的封装技术能够控制释放，确保更高的稳定性和功效，促进医药与化妆品的合作。此外，兼顾治疗和美容需求的多功能产品正在推动创新管道的拓展。随着消费者对个人化护肤的偏好日益增长，这些进步为实现更好的产品差异化铺平了道路，加速了烟碱酰胺的普及，并将其定位为多功能经皮成分。

可能引起皮肤刺激和过敏反应

长期高浓度使用会导致皮肤发红、接触性皮肤炎，并破坏敏感肌肤的屏障，进而影响顺从性。监管机构强调严格的皮肤病学测试，从而延长新配方的上市时间。此外，消费者对刺激性的负面评价可能会损害产品的声誉，尤其是在化妆品管道。由于安全认知持续显着影响患者和消费者的接受度，这种风险需要增加对低致敏配方和皮肤病学测试的投资。

COVID-19的影响：

新冠疫情对经皮烟碱酰胺市场产生了多方面的影响。一方面，原材料供应链和生产环节的中断导致分销面临短期挑战，尤其是在新兴经济体。另一方面，由于「口罩痘」疫情以及消费者对居家皮肤护理的重视，消费者对护肤品的需求增加，从而推动了其使用量。此外，电子商务的发展加速了以烟碱酰胺为基础的经皮製剂的商店市场。此外，针对皮肤健康和免疫力的临床研究也强化了烟碱酰胺作为理想活性成分的地位。

凝胶和乳霜类产品预计将成为预测期内最大的市场

凝胶和乳霜类产品预计将在预测期内占据最大的市场占有率，这得益于其使用方便、消费者熟悉度高以及在零售、药局和线上通路的广泛分销。其另一个优点是能够治疗多种皮肤问题，包括痤疮、瑕疵和皮肤屏障功能障碍。消费者对具有抗衰老和美白功效的药用化妆品产品的日益偏好也推动了市场的成长。

预计皮肤病诊所部门在预测期内将出现最高的复合年增长率。

预计在预测期内，皮肤科诊所细分市场将实现最高成长率，这得益于市场对先进个人化护肤疗法日益增长的需求。诊所是提供皮肤科医生推荐配方的可靠管道，尤其适用于患有慢性皮肤病和需要专科医生级别干预的患者。此外，强化的临床研究检验了烟碱酰胺的有效性和安全性，也增强了其在这些专科门市的采用率。由于患者意识的提高以及对循证治疗的重视，预计皮肤科诊所仍将是成长最快的通路。

比最大的地区

预计北美将在预测期内占据最大市场占有率，这主要得益于其皮肤病的高发病率、消费者对高端护肤品的偏好，以及先进给药技术的早期采用。美国和加拿大拥有成熟的製药和化妆品产业，推动产品创新和临床研究。此外，强大的医疗基础设施支持皮肤病治疗，专利主导的研发也增强了市场竞争力。消费者对美白和抗衰老产品的需求不断增长，预计将继续巩固北美在该地区的主导地位。

复合年增长率最高的地区：

预计亚太地区将在预测期内呈现最高的复合年增长率，这得益于消费者护肤意识的不断提升、快速的都市化以及可支配收入的不断增长。中国、日本和韩国等国家正引领护肤创新，将烟碱酰胺融入治疗和化妆品领域。此外，电商平台的扩张和韩妆潮流的兴起正在加速年轻一代对烟碱酰胺的接受度。跨国化妆品公司不断增加对亚太地区生产设施的投资，从而强化了供应链。不断变化的消费行为和对先进配方的偏好，很可能使该地区成为全球成长最快的地区。

分销管道

  • 医院药房
  • 零售店和便利商店
  • 网上零售/电子商务
  • 皮肤科诊所

免费客製化服务

此报告的订阅者可以从以下免费自订选项中选择一项：

  • 公司简介
    • 对最多三家其他公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 简介

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 分析方法
  • 分析材料
    • 主要研究资料
    • 二手研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 市场机会
  • 威胁
  • 应用分析
  • 新兴市场
  • COVID-19的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代产品的威胁
  • 新参与企业的威胁
  • 企业之间的竞争

5. 全球经皮烟碱酰胺市场（依产品形式）

  • 啫咖哩/乳霜
  • 美容精华液
  • 修补
  • 微针贴片

6. 全球经皮烟碱酰胺市场（依分销通路）

  • 医院药房
  • 零售店和便利商店
  • 网上零售/电子商务
  • 皮肤科诊所

7. 全球经皮烟碱酰胺市场（按应用）

  • 皮肤科
    • 粉刺
    • 酒糟/炎症
    • 牛皮癣和其他皮肤病
  • 美容皮肤科
    • 抗衰老
    • 皮肤亮度和色素沉着
    • 皮肤屏障修復

8. 全球经皮烟碱酰胺市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第九章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併与收购（M&A）
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章：企业概况

  • DSM-Firmenich
  • BASF
  • Merck KGaA
  • Lonza
  • Bactolac Pharmaceutical
  • Evonik Industries
  • Givaudan
  • Procter & Gamble
  • Unilever
  • L'Oreal
  • Estee Lauder
  • Beiersdorf
  • Johnson & Johnson
  • Amway
  • Shiseido
  • Coty
  • Paula's Choice
  • The Ordinary（Deciem）
  • Galderma
  • Rohto Pharmaceutical
Product Code: SMRC30503

According to Stratistics MRC, the Global Transdermal Niacinamide Market is accounted for $70.87 million in 2025 and is expected to reach $113.06 million by 2032 growing at a CAGR of 6.9% during the forecast period. Transdermal niacinamide is a dermatological and cosmeceutical solution delivering vitamin B3 directly through the skin via advanced formulations such as patches, gels, or creams. This method enhances bioavailability, bypassing oral metabolism while addressing targeted concerns like acne, hyperpigmentation, and inflammation. Its adoption is fueled by rising preference for non-invasive therapies, evidence-based skincare, and the broader trend toward personalized dermatology, making it a promising segment in medical aesthetics and dermatological care.

According to Springer's Drug Delivery and Translational Research (2024), niacinamide is widely used in topical formulations due to its skin-brightening, anti-aging, and barrier-protective properties. Concentrations up to 20% are used in commercial products, and its efficacy is linked to its role in NAD+/NADH metabolism.

Market Dynamics:

Driver:

Growing prevalence of skin disorders

The growing prevalence of skin disorders continues to drive adoption of transdermal niacinamide formulations, as consumers seek effective solutions for conditions such as hyperpigmentation, acne, and atopic dermatitis. Increasing awareness of niacinamide's dermatological benefits, such as improved skin barrier function and enhanced hydration, further strengthens its demand across both therapeutic and cosmetic segments. Additionally, the rise in aging populations globally is fueling adoption due to rising dermatological concerns. Furthermore, recent innovations in skincare delivery systems integrate niacinamide more effectively, positively contributing to steady market expansion.

Restraint:

High cost of advanced transdermal delivery systems

The high cost associated with advanced delivery mechanisms, including microneedle patches, nanoparticle carriers, and encapsulation technologies, is hampering the growth. These innovations, while improving bioavailability, significantly increase product development and consumer pricing, limiting mass adoption. Additionally, manufacturers face higher R&D expenditures and compliance costs in regulated markets, further impacting affordability. Furthermore, lesser-developed economies often struggle with cost competitiveness compared to traditional oral or topical alternatives. This price sensitivity may restrict uptake, thereby slowing broader market penetration.

Opportunity:

Development of novel delivery mechanisms

The development of novel delivery mechanisms integrates nanotechnology, microneedles, and hydrogel systems for improved skin penetration. Advanced encapsulation technologies provide controlled release, ensuring higher stability and efficacy, thereby attracting pharmaceutical and cosmeceutical collaborations. Additionally, multi-functional products catering to both therapeutic and cosmetic needs are stimulating innovation pipelines. With rising consumer preference for personalized skincare, these advancements open avenues for wider product differentiation, accelerating adoption and positioning niacinamide as a versatile transdermal ingredient.

Threat:

Potential skin irritation and allergic reactions

Prolonged use at higher concentrations may trigger redness, contact dermatitis, or barrier disruption in individuals with sensitive skin, thereby limiting compliance. Regulatory bodies emphasize stringent dermatological testing, increasing time-to-market for new formulations. Furthermore, negative consumer reviews regarding irritation can harm product reputation, particularly across cosmetic channels. This risk necessitates greater investment in hypoallergenic formulations and dermatological trials, as safety perceptions will continue to influence patient and consumer acceptance significantly.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the transdermal niacinamide market. On one hand, disruptions in raw material supply chains and manufacturing led to short-term challenges, particularly in distribution across emerging economies. However, rising consumer demand for skincare products due to "maskne" and emphasis on home-based dermatological care boosted usage. Additionally, e-commerce growth accelerated over-the-counter adoption of niacinamide-based transdermal solutions. Furthermore, clinical research on skin health and immunity strengthened niacinamide's profile as a desirable active ingredient.

The gels & creams segment is expected to be the largest during the forecast period

The gels & creams segment is expected to account for the largest market share during the forecast period, driven by their ease of application, consumer familiarity, and widespread distribution through retail, pharmacy, and online channels. Additionally, this segment benefits from versatility in formulations, addressing multiple skin disorders, including acne, dark spots, and barrier dysfunction. The increasing preference for cosmeceutical products with anti-aging and skin-brightening functions also supports market expansion.

The dermatology clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the dermatology clinics segment is predicted to witness the highest growth rate, supported by growing demand for advanced and personalized skincare treatments. Clinics serve as trusted channels for delivering dermatologist-recommended formulations, especially for patients dealing with chronic skin disorders or requiring professional-grade interventions. Furthermore, enhanced clinical research validating niacinamide's efficacy and safety reinforces adoption through these professional outlets. With increasing patient awareness and the rising emphasis on evidence-based therapies, dermatology clinics are expected to remain the fastest-expanding distribution route.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, primarily due to the high prevalence of skin disorders, growing consumer preference for premium skincare products, and early adoption of advanced delivery technologies. Well-established pharmaceutical and cosmetic industries in the U.S. and Canada are driving product innovations and clinical research. Furthermore, strong healthcare infrastructure supports dermatological treatments, and patent-driven R&D enhances market competitiveness. Increasing consumer demand for skin-brightening and anti-aging solutions will continue to strengthen North America's dominant regional position.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rising consumer awareness of skincare, rapid urbanization, and growing disposable incomes. Countries such as China, Japan, and South Korea are leading in skincare innovation, integrating niacinamide across both therapeutic and cosmetic categories. Additionally, expanding e-commerce platforms and K-beauty trends are accelerating adoption across younger demographics. The increased investments by multinational cosmetic firms in Asia-Pacific manufacturing facilities strengthen supply chains. With evolving consumer behavior and preference for advanced formulations, the region is set to deliver the fastest growth trajectory globally.

Key players in the market

Some of the key players in Transdermal Niacinamide Market include DSM-Firmenich, BASF, Merck KGaA, Lonza, Bactolac Pharmaceutical, Evonik Industries, Givaudan, Procter & Gamble, Unilever, L'Oreal, Estee Lauder, Beiersdorf, Johnson & Johnson, Amway, Shiseido, Coty, Paula's Choice, The Ordinary (Deciem), Galderma, and Rohto Pharmaceutical.

Key Developments:

In October 2024, BASF's Personal Care business is launching a new synthetic peptide for skin care applications. Inspired by the natural regenerative process of the skin, Pepsensyal(TM) (INCI: Mannitol (and) Acetyl sh-Tetrapeptide-1 (and) Lauroyl sh-Tetrapeptide-1) has been clinically proven to reduce and delay the first visible signs of aging. The new ingredient is a response to the slow-aging trend, which reflects a shift in consumer attitudes: Rather than fighting the natural aging process, consumers are increasingly concerned with healthy aging through a holistic, preventative approach to skin care.

In October 2024, DSM-Firmenich has developed an upgraded version of their Niacinamide PC product to mark its 10th anniversary. The enhanced formula provides all the traditional benefits with improved efficacy for menopausal skin concerns, addressing dryness, sensitivity, fine lines, and wrinkles by strengthening the skin barrier. Their research shows 27% reduction in transepidermal water loss when 2% niacinamide was applied twice daily for 4 weeks.

In September 2024, Evonik has launched two new products to meet the demands for sustainable, natural actives in the beauty and personal care markets. The two newly launched products are CapilAcid(TM), an active ingredient derived from the Maqui fruit which is a comprehensive protector and powerful antioxidant for the hair, and Oleobiota(TM), an active ingredient sourced sustainably from the Misiones rainforest for sebum-normalizing skin care. Both products originate from the company Novachem, which was acquired by Evonik one year ago and is being integrated into the company's Care Solutions business.

Product Forms Covered:

  • Gels & Creams
  • Serums
  • Patches
  • Microneedle Patches

Distribution Channels:

  • Hospital Pharmacies
  • Retail & Convenience Stores
  • Online Retail/E-commerce
  • Dermatology Clinics

Applications Covered:

  • Medical Dermatology
  • Cosmetic Dermatology

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Transdermal Niacinamide Market, By Product Form

  • 5.1 Introduction
  • 5.2 Gels & Creams
  • 5.3 Serums
  • 5.4 Patches
  • 5.5 Microneedle Patches

6 Global Transdermal Niacinamide Market, By Distribution Channel

  • 6.1 Introduction
  • 6.2 Hospital Pharmacies
  • 6.3 Retail & Convenience Stores
  • 6.4 Online Retail/E-commerce
  • 6.5 Dermatology Clinics

7 Global Transdermal Niacinamide Market, By Application

  • 7.1 Introduction
  • 7.2 Medical Dermatology
    • 7.2.1 Acne
    • 7.2.2 Rosacea & Inflammation
    • 7.2.3 Psoriasis & Other Skin Conditions
  • 7.3 Cosmetic Dermatology
    • 7.3.1 Anti-aging
    • 7.3.2 Skin Brightening & Pigmentation
    • 7.3.3 Skin Barrier Repair

8 Global Transdermal Niacinamide Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 DSM-Firmenich
  • 10.2 BASF
  • 10.3 Merck KGaA
  • 10.4 Lonza
  • 10.5 Bactolac Pharmaceutical
  • 10.6 Evonik Industries
  • 10.7 Givaudan
  • 10.8 Procter & Gamble
  • 10.9 Unilever
  • 10.10 L'Oreal
  • 10.11 Estee Lauder
  • 10.12 Beiersdorf
  • 10.13 Johnson & Johnson
  • 10.14 Amway
  • 10.15 Shiseido
  • 10.16 Coty
  • 10.17 Paula's Choice
  • 10.18 The Ordinary (Deciem)
  • 10.19 Galderma
  • 10.20 Rohto Pharmaceutical

List of Tables

  • Table 1 Global Transdermal Niacinamide Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Transdermal Niacinamide Market Outlook, By Product Form (2024-2032) ($MN)
  • Table 3 Global Transdermal Niacinamide Market Outlook, By Gels & Creams (2024-2032) ($MN)
  • Table 4 Global Transdermal Niacinamide Market Outlook, By Serums (2024-2032) ($MN)
  • Table 5 Global Transdermal Niacinamide Market Outlook, By Patches (2024-2032) ($MN)
  • Table 6 Global Transdermal Niacinamide Market Outlook, By Microneedle Patches (2024-2032) ($MN)
  • Table 7 Global Transdermal Niacinamide Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 8 Global Transdermal Niacinamide Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 9 Global Transdermal Niacinamide Market Outlook, By Retail & Convenience Stores (2024-2032) ($MN)
  • Table 10 Global Transdermal Niacinamide Market Outlook, By Online Retail/E-commerce (2024-2032) ($MN)
  • Table 11 Global Transdermal Niacinamide Market Outlook, By Dermatology Clinics (2024-2032) ($MN)
  • Table 12 Global Transdermal Niacinamide Market Outlook, By Application (2024-2032) ($MN)
  • Table 13 Global Transdermal Niacinamide Market Outlook, By Medical Dermatology (2024-2032) ($MN)
  • Table 14 Global Transdermal Niacinamide Market Outlook, By Acne (2024-2032) ($MN)
  • Table 15 Global Transdermal Niacinamide Market Outlook, By Rosacea & Inflammation (2024-2032) ($MN)
  • Table 16 Global Transdermal Niacinamide Market Outlook, By Psoriasis & Other Skin Conditions (2024-2032) ($MN)
  • Table 17 Global Transdermal Niacinamide Market Outlook, By Cosmetic Dermatology (2024-2032) ($MN)
  • Table 18 Global Transdermal Niacinamide Market Outlook, By Anti-aging (2024-2032) ($MN)
  • Table 19 Global Transdermal Niacinamide Market Outlook, By Skin Brightening & Pigmentation (2024-2032) ($MN)
  • Table 20 Global Transdermal Niacinamide Market Outlook, By Skin Barrier Repair (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.